Cargando…
Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
Background: Patients with chronic obstructive pulmonary disease (COPD) often suffer from multiple morbidities, which occur in clusters and are sometimes related to accelerated aging. This study aimed to assess the disease specificity of comorbidity clusters in COPD and their association with a bioma...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517869/ https://www.ncbi.nlm.nih.gov/pubmed/31013986 http://dx.doi.org/10.3390/jcm8040511 |
_version_ | 1783418340533862400 |
---|---|
author | Triest, Filip J. J. Franssen, Frits M. E. Reynaert, Niki Gaffron, Swetlana Spruit, Martijn A. Janssen, Daisy J. A. Rutten, Erica P. A. Wouters, Emiel F. M. Vanfleteren, Lowie E. G. W. |
author_facet | Triest, Filip J. J. Franssen, Frits M. E. Reynaert, Niki Gaffron, Swetlana Spruit, Martijn A. Janssen, Daisy J. A. Rutten, Erica P. A. Wouters, Emiel F. M. Vanfleteren, Lowie E. G. W. |
author_sort | Triest, Filip J. J. |
collection | PubMed |
description | Background: Patients with chronic obstructive pulmonary disease (COPD) often suffer from multiple morbidities, which occur in clusters and are sometimes related to accelerated aging. This study aimed to assess the disease specificity of comorbidity clusters in COPD and their association with a biomarker of accelerated aging as a potential mechanistic factor. Methods: Body composition, metabolic, cardiovascular, musculoskeletal, and psychological morbidities were objectively evaluated in 208 COPD patients (age 62 ± 7 years, 58% males, FEV(1) 50 ± 16% predicted) and 200 non-COPD controls (age 61 ± 7 years, 45% males). Based on their presence and severity, the morbidities were clustered to generate distinct clusters in COPD and controls. Telomere length in circulating leukocytes was compared across the clusters. Results: (co)morbidities were more prevalent in COPD patients compared to controls (3.9 ± 1.7 vs. 2.4 ± 1.5, p < 0.05). A “Psychologic” and “Cachectic” cluster were only present in the COPD population. “Less (co)morbidity”, “Cardiovascular”, and “Metabolic” clusters were also observed in controls, although with less complexity. Telomere length was reduced in COPD patients, but did not differ between the (co)morbidity clusters in both populations. Conclusions: Two COPD-specific comorbidity clusters, a “Cachectic” and “Psychologic” cluster, were identified and warrant further studies regarding their development. Accelerated aging was present across various multimorbidity clusters in COPD. |
format | Online Article Text |
id | pubmed-6517869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65178692019-05-31 Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging Triest, Filip J. J. Franssen, Frits M. E. Reynaert, Niki Gaffron, Swetlana Spruit, Martijn A. Janssen, Daisy J. A. Rutten, Erica P. A. Wouters, Emiel F. M. Vanfleteren, Lowie E. G. W. J Clin Med Article Background: Patients with chronic obstructive pulmonary disease (COPD) often suffer from multiple morbidities, which occur in clusters and are sometimes related to accelerated aging. This study aimed to assess the disease specificity of comorbidity clusters in COPD and their association with a biomarker of accelerated aging as a potential mechanistic factor. Methods: Body composition, metabolic, cardiovascular, musculoskeletal, and psychological morbidities were objectively evaluated in 208 COPD patients (age 62 ± 7 years, 58% males, FEV(1) 50 ± 16% predicted) and 200 non-COPD controls (age 61 ± 7 years, 45% males). Based on their presence and severity, the morbidities were clustered to generate distinct clusters in COPD and controls. Telomere length in circulating leukocytes was compared across the clusters. Results: (co)morbidities were more prevalent in COPD patients compared to controls (3.9 ± 1.7 vs. 2.4 ± 1.5, p < 0.05). A “Psychologic” and “Cachectic” cluster were only present in the COPD population. “Less (co)morbidity”, “Cardiovascular”, and “Metabolic” clusters were also observed in controls, although with less complexity. Telomere length was reduced in COPD patients, but did not differ between the (co)morbidity clusters in both populations. Conclusions: Two COPD-specific comorbidity clusters, a “Cachectic” and “Psychologic” cluster, were identified and warrant further studies regarding their development. Accelerated aging was present across various multimorbidity clusters in COPD. MDPI 2019-04-14 /pmc/articles/PMC6517869/ /pubmed/31013986 http://dx.doi.org/10.3390/jcm8040511 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Triest, Filip J. J. Franssen, Frits M. E. Reynaert, Niki Gaffron, Swetlana Spruit, Martijn A. Janssen, Daisy J. A. Rutten, Erica P. A. Wouters, Emiel F. M. Vanfleteren, Lowie E. G. W. Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging |
title | Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging |
title_full | Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging |
title_fullStr | Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging |
title_full_unstemmed | Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging |
title_short | Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging |
title_sort | disease-specific comorbidity clusters in copd and accelerated aging |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517869/ https://www.ncbi.nlm.nih.gov/pubmed/31013986 http://dx.doi.org/10.3390/jcm8040511 |
work_keys_str_mv | AT triestfilipjj diseasespecificcomorbidityclustersincopdandacceleratedaging AT franssenfritsme diseasespecificcomorbidityclustersincopdandacceleratedaging AT reynaertniki diseasespecificcomorbidityclustersincopdandacceleratedaging AT gaffronswetlana diseasespecificcomorbidityclustersincopdandacceleratedaging AT spruitmartijna diseasespecificcomorbidityclustersincopdandacceleratedaging AT janssendaisyja diseasespecificcomorbidityclustersincopdandacceleratedaging AT ruttenericapa diseasespecificcomorbidityclustersincopdandacceleratedaging AT woutersemielfm diseasespecificcomorbidityclustersincopdandacceleratedaging AT vanfleterenlowieegw diseasespecificcomorbidityclustersincopdandacceleratedaging |